Healthcare & Medical Investment Corporation (TYO:3455)
124,700
-300 (-0.24%)
At close: Mar 13, 2026
TYO:3455 Income Statement
Financials in millions JPY. Fiscal year is February - January.
Millions JPY. Fiscal year is Feb - Jan.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '25 Jul 31, 2025 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 | Jan '21 Jan 31, 2021 |
Rental Revenue | 5,065 | 5,036 | 4,877 | 4,799 | 4,153 | 4,081 |
Gain (Loss) on Sale of Assets (Rev) | - | - | - | 204.65 | - | - |
Gain (Loss) on Sale of Investments (Rev) | 1.53 | 1.53 | - | - | - | - |
Other Revenue | 3 | - | 0 | 0 | - | - |
| 5,070 | 5,037 | 4,877 | 5,003 | 4,153 | 4,081 | |
Revenue Growth (YoY | 2.36% | 3.29% | -2.53% | 20.48% | 1.76% | 1.49% |
Property Expenses | 2,293 | 2,288 | 2,193 | 2,106 | 1,789 | 1,727 |
Selling, General & Administrative | 50.88 | 48.19 | 44.67 | 57.6 | 56 | 55 |
Other Operating Expenses | 166.77 | 128.72 | 117.14 | 120.32 | 156 | 159 |
Total Operating Expenses | 2,510 | 2,465 | 2,354 | 2,284 | 2,001 | 1,941 |
Operating Income | 2,560 | 2,572 | 2,523 | 2,719 | 2,152 | 2,140 |
Interest Expense | -447.78 | -353.75 | -277.71 | -213.07 | -300 | -297 |
Interest & Investment Income | 1.27 | 0.29 | 0.15 | 0.09 | - | - |
Other Non-Operating Income | -72.39 | -139.31 | -128.13 | -128.15 | -6 | -4 |
EBT Excluding Unusual Items | 2,041 | 2,079 | 2,117 | 2,378 | 1,846 | 1,839 |
Total Insurance Settlements | 1.77 | 1.77 | 2.34 | 1.82 | - | - |
Other Unusual Items | - | - | - | - | -12 | -12 |
Pretax Income | 2,043 | 2,081 | 2,119 | 2,380 | 1,834 | 1,827 |
Income Tax Expense | 0.9 | 1.81 | 1.76 | 1.63 | - | - |
Net Income | 2,042 | 2,079 | 2,117 | 2,379 | 1,834 | 1,827 |
Net Income to Common | 2,042 | 2,079 | 2,117 | 2,379 | 1,834 | 1,827 |
Net Income Growth | -2.98% | -1.79% | -10.98% | 29.69% | 0.38% | -8.14% |
Basic Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 |
Diluted Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 |
Shares Change (YoY) | - | - | 0.05% | 15.54% | - | 0.13% |
EPS (Basic) | 5679.01 | 5784.27 | 5889.94 | 6619.45 | 5897.09 | 5874.58 |
EPS (Diluted) | 5679.01 | 5784.27 | 5889.94 | 6619.45 | 5897.09 | 5874.58 |
EPS Growth | -2.98% | -1.79% | -11.02% | 12.25% | 0.38% | -8.26% |
Dividend Per Share | 3183.000 | 6444.000 | 6517.000 | 6924.000 | - | - |
Dividend Growth | -51.00% | -1.12% | -5.88% | - | - | - |
Operating Margin | 50.49% | 51.06% | 51.72% | 54.35% | 51.82% | 52.44% |
Profit Margin | 40.27% | 41.28% | 43.42% | 47.54% | 44.16% | 44.77% |
EBITDA | 3,763 | 3,761 | 3,649 | 3,835 | 3,120 | 3,073 |
EBITDA Margin | 74.23% | 74.66% | 74.83% | 76.65% | 75.13% | 75.30% |
D&A For Ebitda | 1,204 | 1,188 | 1,127 | 1,116 | 968 | 933 |
EBIT | 2,560 | 2,572 | 2,523 | 2,719 | 2,152 | 2,140 |
EBIT Margin | 50.49% | 51.06% | 51.72% | 54.35% | 51.82% | 52.44% |
Funds From Operations (FFO) | 1,622 | 3,266 | 3,243 | 3,289 | - | - |
Adjusted Funds From Operations (AFFO) | - | 3,266 | 3,243 | 3,289 | - | - |
FFO Payout Ratio | 142.80% | 71.49% | 75.77% | 67.42% | - | - |
Effective Tax Rate | 0.04% | 0.09% | 0.08% | 0.07% | - | - |
Revenue as Reported | 2,523 | 5,037 | 4,877 | 5,003 | - | - |
Source: S&P Global Market Intelligence. Real Estate template. Financial Sources.